Sunesis Pharmaceuticals to Host Conference Call on November 16th to Discuss Third Quarter 2020 Financial Results and Recent H...
09 Novembro 2020 - 9:00AM
Sunesis Pharmaceuticals, Inc. (Nasdaq: SNSS) today announced
that it will host a conference call on Monday, November 16th, 2020
at 4:30pm Eastern Time to discuss corporate updates and financial
results for the third quarter ended September 30, 2020.
The call can be accessed by dialing (844)
296-7720 (U.S. and Canada) or (574) 990-1148 (international)
and entering passcode 1776248.
To access the live audio webcast, or the
subsequent archived recording, visit the “Investors and Media –
Calendar of Events” section of the Sunesis website
at www.sunesis.com. The webcast will be recorded and available
for replay on the company’s website for two weeks.
About Sunesis
Pharmaceuticals
Sunesis is a biopharmaceutical company
developing novel targeted inhibitors for the treatment of
hematologic and solid cancers. Sunesis has built an experienced
drug development organization committed to improving the lives of
people with cancer. The Company is focused on advancing its novel
kinase inhibitor pipeline, including first-in-class PDK1 inhibitor
SNS-510. SNS-510 is in IND-enabling studies and vecabrutinib has
completed a Phase 1b trial in patients with advanced B cell
malignancies.
For additional information on Sunesis, please
visit www.sunesis.com.
SUNESIS and the logos are trademarks
of Sunesis Pharmaceuticals, Inc.
Investor and Media Inquiries:Maeve ConneightonArgot
Partners212-600-1902 |
Par HyareSunesis Pharmaceuticals Inc.650-266-3784 |
Sunesis Pharmaceuticals (NASDAQ:SNSS)
Gráfico Histórico do Ativo
De Nov 2024 até Dez 2024
Sunesis Pharmaceuticals (NASDAQ:SNSS)
Gráfico Histórico do Ativo
De Dez 2023 até Dez 2024
Notícias em tempo-real sobre Sunesis Pharmaceuticals Inc da NASDAQ bolsa de valores: 0 artigos recentes
Mais Notícias de